Evidence map›Paper›PMID 35280429›Full record

ArticleAnnals of translational medicine2022

Knockdown of

Qian Shen, Qi Jiang, Zhirong Cong, Yin Zhou, Xiaoxiao Huang, Li Zhu, Xiaohong Xu, Juan Qian

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Long non‑coding RNAs in multiple myeloma (Review).International journal of oncology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Qian Shen *Department of Hematology & Lymphoma, Affiliated Tumor Hospital of Nantong University, Nantong, China.
Qi Jiang *Department of Hematology & Lymphoma, Affiliated Tumor Hospital of Nantong University, Nantong, China.
Zhirong CongDepartment of Hematology & Lymphoma, Affiliated Tumor Hospital of Nantong University, Nantong, China.
Yin ZhouDepartment of Hematology & Lymphoma, Affiliated Tumor Hospital of Nantong University, Nantong, China.
Xiaoxiao HuangDepartment of Laboratory, Affiliated Tumor Hospital of Nantong University, Nantong, China.
Li ZhuDepartment of Hematology & Lymphoma, Affiliated Tumor Hospital of Nantong University, Nantong, China.
Xiaohong XuDepartment of Hematology & Lymphoma, Affiliated Tumor Hospital of Nantong University, Nantong, China.
Juan QianDepartment of Hematology, Affiliated Hospital of Nantong University, Nantong, China.
Nantong University · CNNantong Tumor Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple myeloma (MM) is a B-lymphocyte-derived malignancy. It ranks as the second most common hematological malignancy, with relatively high morbidity and mortality. However, the molecular mechanisms of MM occurrence and development remain elusive. This study found that long non-coding RNA AL928768.3 ( Methods: Bone marrow fluids of MM patients (n=54) and volunteers (n=13) were collected and CD138 Results: Conclusions:

Indexed as

G0/G1 phaselong non-coding RNAs (lncRNAs)Multiple myeloma (MM)

Identifiers

PMID35280429
PMCPMC8908156
OpenAlexW4213418313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.